CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin β4 and Cd9 pathway
- PMID: 39873228
- DOI: 10.1093/eurheartj/ehae911
CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin β4 and Cd9 pathway
Abstract
Background and aims: Members of the CCN matricellular protein family are crucial in various biological processes. This study aimed to characterize vascular cell-specific effects of CCN5 on neointimal formation and its role in preventing in-stent restenosis (ISR) after percutaneous coronary intervention (PCI).
Methods: Stent-implanted porcine coronary artery RNA-seq and mouse injury-induced femoral artery neointima single-cell RNA sequencing were performed. Plasma CCN5 levels were measured by enzyme-linked immunosorbent assay. Endothelial cell (EC)- and vascular smooth muscle cell (VSMC)-specific CCN5 loss-of-function and gain-of-function mice were generated. Mass spectrometry and co-immunoprecipitation were conducted to identify CCN5 interacting proteins. Additionally, CCN5 recombinant protein (CCN5rp)-coated stents were deployed to evaluate its anti-ISR effects in a porcine model.
Results: Plasma CCN5 levels were significantly reduced and correlated closely with the degree of restenosis in ISR patients. CCN5 expression was significantly decreased in VSMCs of stent-implanted porcine coronary segments and injured mouse femoral arteries, especially in synthetic VSMCs. In contrast, elevated CCN5 expression was observed in regenerating ECs of injured vessels. Endothelial cell- and VSMC-specific CCN5 deletion mice exhibited exacerbation of injury-induced neointimal hyperplasia, while CCN5 gain-of-function alleviated neointimal formation. Mechanistic studies identified thymosin β4 (Tβ4) as a CCN5 interacting protein in ECs and EC-CCN5 promoted injury repair through Tβ4 cleavage product Ac-SDKP. Also, CCN5rp promoted EC repair to suppress neointimal hyperplasia via interaction with Cd9 extracellular domain. Moreover, implantation with CCN5rp-coated stent significantly increased stent strut coverage with ECs, which suppressed neointimal formation and ultimately alleviated ISR.
Conclusions: CCN5 exerts a dual protective effect on ISR by inhibiting VSMC proliferation and facilitating EC repair. CCN5rp-coated stent might be promising in the prevention of ISR after PCI.
Keywords: Cellular communication network factor 5 (CCN5); EC repair; In-stent restenosis; Neointimal hyperplasia; Thymosin β4; VSMC proliferation and migration.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Similar articles
-
Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):717-729. doi: 10.1161/ATVBAHA.116.308210. Epub 2017 Feb 9. Arterioscler Thromb Vasc Biol. 2017. PMID: 28183701
-
Buyang huanwu decoction attenuates arterial in-stent restenosis via transforming growth factor beta receptor 1-mediated suppression of neointimal hyperplasia.J Ethnopharmacol. 2025 Aug 29;352:120244. doi: 10.1016/j.jep.2025.120244. Epub 2025 Jul 3. J Ethnopharmacol. 2025. PMID: 40617364
-
Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway.J Mol Cell Cardiol. 2020 Feb;139:1-13. doi: 10.1016/j.yjmcc.2020.01.006. Epub 2020 Jan 17. J Mol Cell Cardiol. 2020. PMID: 31958462
-
Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.Circ J. 2011;75(6):1287-96. doi: 10.1253/circj.cj-11-0366. Epub 2011 Apr 29. Circ J. 2011. PMID: 21532177 Review.
-
Noncoding RNAs in vascular smooth muscle cell function and neointimal hyperplasia.FEBS J. 2020 Dec;287(24):5260-5283. doi: 10.1111/febs.15357. Epub 2020 May 22. FEBS J. 2020. PMID: 32367680 Review.
Cited by
-
Targeted approach for next-generation coronary stents.Eur Heart J. 2025 May 2;46(17):1659-1661. doi: 10.1093/eurheartj/ehaf007. Eur Heart J. 2025. PMID: 40037368 No abstract available.
MeSH terms
Substances
Grants and funding
- 2022YFA1104503/National Key Research and Development Program
- 82130016/National Natural Science Foundation of China
- Sino-German Center Mobility Program
- 21QA1401400/Shanghai Rising-Star Program
- PWRq2021-04/Young Medical Talents Training Program of Pudong Health Bureau of Shanghai
- 2022YQ069/Young Health Talents of Shanghai Municipal Health Commission
- ZDSYS14005/Education Commission of Shanghai Municipality
- PWZxq2022-02/Key Disciplines Group Construction Project of Shanghai Pudong New Area Health Commission
- PWYgf2021-01/the Top-level Clinical Discipline Project of Shanghai Pudong
- JCYJ20220530163603008/Shenzhen Science and Technology Innovation Committee
- 2023A1515010880/Natural Science Foundation of Guangdong Province
LinkOut - more resources
Full Text Sources
Miscellaneous